We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PIQLF market cap is 40.58M. The company's latest EPS is AUD -0.0487 and P/E is -13.14.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 3M | 2.97M | 3.43M | 3.17M | 3.27M |
| Operating Income | -1.74M | -2.85M | -4.98M | -6.38M | -6.75M |
| Net Income | -1.74M | -2.86M | -4.97M | -6.18M | -6.38M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.56M | 8.6M | 5.4M | 10.08M | 10.88M |
| Total Liabilities | 1.12M | 991k | 2M | 1.75M | 1.63M |
| Total Equity | 4.44M | 7.61M | 3.39M | 8.32M | 9.25M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -385k | -2.21M | -3.54M | -5.69M | -5.59M |
| Investing | -1.59M | -191k | -129k | -1.17M | -388k |
| Financing | 2.82M | 5.64M | 176k | 10.77M | 6.59M |
| Market Cap | 40.58M |
| Price to Earnings Ratio | -13.14 |
| Price to Sales Ratio | 25.6 |
| Price to Cash Ratio | 12.62 |
| Price to Book Ratio | 9.06 |
| Dividend Yield | - |
| Shares Outstanding | 130.89M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 25k |
| 52 Week Change | 0.00% |
| 52 Week High | 0.31 |
| 52 Week Low | 0.31 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Proteomics International Laboratories Ltd (PK) |
| Address |
suite 13 perth, western australia 6005 |
| Website | https://www.proteomicsinternational.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
